ATE460929T1 - Topische präparate mit einem hydrophilen träger und einer silikonmatrix - Google Patents

Topische präparate mit einem hydrophilen träger und einer silikonmatrix

Info

Publication number
ATE460929T1
ATE460929T1 AT04780975T AT04780975T ATE460929T1 AT E460929 T1 ATE460929 T1 AT E460929T1 AT 04780975 T AT04780975 T AT 04780975T AT 04780975 T AT04780975 T AT 04780975T AT E460929 T1 ATE460929 T1 AT E460929T1
Authority
AT
Austria
Prior art keywords
silicone matrix
hydrophilic carrier
topical preparations
skin
active agent
Prior art date
Application number
AT04780975T
Other languages
English (en)
Inventor
Richard Bott
Mark Gebert
Paal Klykken
Isabelle Mazeaud
Xavier Thomas
Original Assignee
Dow Corning
Genencor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning, Genencor Int filed Critical Dow Corning
Application granted granted Critical
Publication of ATE460929T1 publication Critical patent/ATE460929T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622—Microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
AT04780975T 2003-09-10 2004-08-13 Topische präparate mit einem hydrophilen träger und einer silikonmatrix ATE460929T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/660,101 US7223386B2 (en) 2002-03-11 2003-09-10 Preparations for topical skin use and treatment
PCT/US2004/026218 WO2005025548A1 (en) 2003-09-10 2004-08-13 Topical preparations comprising a hydrophilic carrier and a silicone matrix

Publications (1)

Publication Number Publication Date
ATE460929T1 true ATE460929T1 (de) 2010-04-15

Family

ID=34312711

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04780975T ATE460929T1 (de) 2003-09-10 2004-08-13 Topische präparate mit einem hydrophilen träger und einer silikonmatrix

Country Status (9)

Country Link
US (3) US7223386B2 (de)
EP (1) EP1663177B1 (de)
JP (1) JP4993184B2 (de)
KR (1) KR101121461B1 (de)
CN (1) CN1849114B (de)
AT (1) ATE460929T1 (de)
CA (1) CA2537250C (de)
DE (1) DE602004026080D1 (de)
WO (1) WO2005025548A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007509954A (ja) * 2003-10-27 2007-04-19 ダウ コーニング コーポレーション 局所的な適用のための徐放性の組成物及び基体へ活性な作用薬を配送する方法
US20070218115A1 (en) * 2003-10-27 2007-09-20 Bott Richard R Preparation for Topical Application and Methods of Delivering an Active Agent to a Substrate
KR100558751B1 (ko) * 2004-10-18 2006-03-14 주식회사 태평양 피부보습용 화장료 조성물
WO2006138035A1 (en) * 2005-06-13 2006-12-28 Dow Corning Corporation Vehicle for the delivery of topical lipid soluble pharmaceutical agents
US8034323B2 (en) * 2005-12-21 2011-10-11 Avon Products, Inc. Cosmetic compositions having in-situ silicone condensation cross-linking
WO2008136699A1 (fr) * 2007-05-04 2008-11-13 Igor Alexandrovich Bazikov Patch transdermique à microcapsules et procédé de fabrication correspondant
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
EP3574909B1 (de) * 2008-01-30 2026-03-04 Imbed Biosciences, Inc. Polyelektrolytmultilayer enhaltend silber zur wundheilung
RU2585373C2 (ru) * 2009-12-08 2016-05-27 Смит & Невью Ортопедикс АГ Ферментная композиция и способ обработки ран
WO2011100425A2 (en) * 2010-02-10 2011-08-18 Wound Engineering Llc Methods and compositions for wound healing
CZ308891B6 (cs) * 2014-10-01 2021-08-11 Wald Pharmaceuticals s.r.o Aplikační směs pro zvýšení účinnosti antiseptik a/nebo dezinficiens, aplikační prostředek obsahující aplikační směs, a použití této směsi
US20160101166A1 (en) * 2014-10-10 2016-04-14 Rochal Industries, Llp Compositions and kits for treating pruritus and methods of using the same
US10238719B2 (en) 2014-10-10 2019-03-26 Rochal Industries, Llc Compositions and kits for enzymatic debridement and methods of using the same
US9592280B2 (en) * 2014-10-10 2017-03-14 Rochal Industries Llc Compositions and kits for enzymatic debridement and methods of using the same
CN109843343A (zh) 2016-07-29 2019-06-04 因贝德生物科学公司 用于伤口愈合的方法和组合物
CN106386862A (zh) * 2016-08-31 2017-02-15 江西天人生态股份有限公司 一种展膜油悬浮剂及其在防治水稻土传病害方面的应用
TWI615159B (zh) * 2017-07-07 2018-02-21 泰陞國際科技股份有限公司 液體皮膚保護組合物
ES2900255T3 (es) 2017-09-04 2022-03-16 Lts Lohmann Therapie Systeme Ag Sistema de administración transdérmica que incluye un emulsionante
US11878050B2 (en) * 2018-07-16 2024-01-23 Texas Tech University System Glycoside hydrolases to treat biofilm-associated infections
WO2022115858A1 (en) * 2020-11-25 2022-06-02 Topix Pharmaceuticals, Inc. Scar treatment composition

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736721A (en) * 1952-10-08 1956-02-28 Optionally
US2814601A (en) * 1954-04-29 1957-11-26 Dow Corning Organopolysiloxane adhesive and pressure-sensitive adhesive tape containing same
DE1017883B (de) * 1954-07-08 1957-10-17 Fellows Gear Shaper Co Schalt- und Vorschubeinrichtung fuer Zahnradherstellungsmaschinen
US3528940A (en) * 1966-12-15 1970-09-15 Gen Electric Silicone pressure-sensitive adhesive of improved strength
GB1372034A (en) 1970-12-31 1974-10-30 Unilever Ltd Detergent compositions
US4053580A (en) 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
AU573730B2 (en) * 1982-10-25 1988-06-23 Antarctic Pharma Ab Enzyme composition from euphausiaceae (antarctic krill) as cleaning agent
US4760025A (en) * 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
US5801038A (en) * 1984-05-29 1998-09-01 Genencor International Inc. Modified subtilisins having amino acid alterations
US5972682A (en) * 1984-05-29 1999-10-26 Genencor International, Inc. Enzymatically active modified subtilisins
JPH0697997B2 (ja) * 1985-08-09 1994-12-07 ギスト ブロカデス ナ−ムロ−ゼ フエンノ−トチヤツプ 新規の酵素的洗浄剤添加物
US5389536A (en) * 1986-11-19 1995-02-14 Genencor, Inc. Lipase from Pseudomonas mendocina having cutinase activity
GB8704755D0 (en) 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
FR2618337B1 (fr) * 1987-07-22 1989-12-15 Dow Corning Sa Pansement chirurgical et procede pour le fabriquer
FR2653438B1 (fr) * 1989-10-23 1993-06-11 Dow Corning Sa Composition de silicone expansible et son utilisation.
US5145937A (en) * 1989-11-09 1992-09-08 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Polyimides with carbonyl and ether connecting groups between the aromatic rings
CA2046802C (en) * 1990-08-15 2007-05-22 Donald Zane Fortney Compositions containing protease produced by vibrio and method of use in debridement and wound healing
FR2673948B1 (fr) 1991-03-13 1995-03-10 Dow Corning Sa Compositions de silicone expansibles utiles a la realisation de pansements medicaux.
FR2681246B1 (fr) * 1991-04-05 1995-02-10 Oreal Composition cosmetique sous forme d'emulsion triple.
US5232702A (en) * 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
FR2686510A1 (fr) 1992-01-27 1993-07-30 Oreal Emulsion eau-dans-huile stable au cours du temps a haute teneur en silicone.
DE69331907T2 (de) * 1992-09-24 2002-09-05 Genencor International, Inc. Neue alkalische proteasen enthaltende reinigungsmittelzusammensetzungen
GB9316323D0 (en) 1993-08-06 1993-09-22 Procter & Gamble Cosmetic compositions
FR2715563B1 (fr) * 1994-01-31 1996-03-15 Oreal Emulsion stabilisée, destinée à hydrater la peau et son utilisation.
FR2725366B1 (fr) * 1994-10-10 1996-11-22 Oreal Composition cosmetique comprenant des huiles siliconees
CA2222133C (en) * 1995-06-07 2002-12-24 Cygnus, Inc. Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
GB9519094D0 (en) * 1995-09-19 1995-11-22 Warwick Int Group Granulated active with controlled release
US5976682A (en) * 1996-03-12 1999-11-02 Tenneco Packaging Stretch wrap films
US6060546A (en) * 1996-09-05 2000-05-09 General Electric Company Non-aqueous silicone emulsions
AR016969A1 (es) * 1997-10-23 2001-08-01 Procter & Gamble VARIANTE DE PROTEASA, ADN, VECTOR DE EXPRESIoN, MICROORGANISMO HUESPED, COMPOSICIoN DE LIMPIEZA, ALIMENTO PARA ANIMALES Y COMPOSICIoN PARA TRATAR UN TEXTIL
BR9904799A (pt) * 1998-01-08 2001-07-31 Dsm Nv Aplicação tópica de enzimas usando um filme descamável
EP0955347B1 (de) 1998-05-06 2011-08-31 Dow Corning France S.A. Verfahren zum Kleben von Substraten mit Silikongel enthaltenden klebenden Vorrichtungen
EP0966972B1 (de) 1998-06-18 2003-09-24 Dow Corning France S.A. Topische Zusammensetzung enthaltend Silicon-gummi
FR2780645B1 (fr) 1998-07-06 2000-08-11 Oreal Produit pour application topique contenant une lipase, un precurseur de vitamine et un alcool gras
FR2783713B1 (fr) * 1998-09-29 2002-05-31 Oreal Utilisation d'une gomme de silicone pour stabiliser l'acide ascorbique et nouvelles compositions contenant ces composants
US6207717B1 (en) * 1999-01-12 2001-03-27 Dow Corning Corporation Entrapment of vitamins with an elastomeric silicone polyether
US6337086B1 (en) * 1999-02-06 2002-01-08 Dow Corning Corporation Pressure sensitive adhesive compositions for transdermal drug delivery devices
US6200581B1 (en) * 1999-04-28 2001-03-13 Dow Corning Corporation Elastomeric silicone terpolymer
US6168782B1 (en) * 1999-05-24 2001-01-02 Dow Corning Corporation Elastomeric silicone containing an active ingredient
US6238657B1 (en) * 1999-07-12 2001-05-29 Dow Corning Corporation Oil-in-oil and three-phase emulsions
EP1215965B1 (de) 1999-09-16 2003-11-12 Durminster Limited Verfahren und zusammensetzung zur arthropodenbekämpfung
GB0007140D0 (en) 1999-09-27 2000-05-17 Dow Corning Sa Scar treatment composition
US6080394A (en) * 1999-11-08 2000-06-27 Dow Corning Corporation Polar solvent-in-oil emulsions and multiple emulsions
JP2001278738A (ja) * 2000-03-30 2001-10-10 Kose Corp 油中水型乳化化粧料
DE10107628A1 (de) 2001-02-15 2002-08-22 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen in Form von W/O-Emulsionen mit einem Gehalt an Siliconölen und Talkum
US20030180281A1 (en) * 2002-03-11 2003-09-25 Bott Richard R. Preparations for topical skin use and treatment
US7235249B2 (en) 2002-03-28 2007-06-26 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions

Also Published As

Publication number Publication date
CN1849114A (zh) 2006-10-18
US20070190152A1 (en) 2007-08-16
CA2537250A1 (en) 2005-03-24
JP2007505107A (ja) 2007-03-08
EP1663177B1 (de) 2010-03-17
US20070148199A1 (en) 2007-06-28
EP1663177A1 (de) 2006-06-07
KR101121461B1 (ko) 2012-03-16
US20040105874A1 (en) 2004-06-03
US7223386B2 (en) 2007-05-29
DE602004026080D1 (de) 2010-04-29
WO2005025548A1 (en) 2005-03-24
CN1849114B (zh) 2011-02-02
CA2537250C (en) 2013-01-22
JP4993184B2 (ja) 2012-08-08
KR20060119946A (ko) 2006-11-24

Similar Documents

Publication Publication Date Title
ATE460929T1 (de) Topische präparate mit einem hydrophilen träger und einer silikonmatrix
WO2003101404A3 (en) Preparations for topical skin use and treatment
DK0892638T3 (da) Liposombaseret, topisk vitamin D-præparat
ATE429947T1 (de) Vorrichtung zur topischen verabreichung
TW200505508A (en) Methods of administering a dermatological agent to a subject
DE602005013422D1 (de) Formulierungen mit ceramiden und/oder pseudoceramiden und (alpha-)bisabolol zur behandlung von hautschäden
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
ATE386533T1 (de) Kosmetische zubereitungen enthaltend polyhexamethhylenbiguanid-hydrochlorid und distearyldimethylammoniumchlorid
TW200637529A (en) Topical patch cooling preparation and methods for using the same
CA2291144A1 (en) Topical treatment of psoriasis using neutralizing antibodies to il-8
DK1345595T3 (da) Ionstyrke-uafhængig farmaceutisk formulering med depotfrigivelse
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
BR9908713A (pt) Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
WO2003057172A3 (en) Topical application of alpha-dfmo and anti-inflammatory drug for treatment of actinic keratoses
ATE335501T1 (de) Mittel zur behandlung von allergischen oder überempfindlichkeitszuständen
ATE326520T1 (de) Teilchen für flüssige zubereitungen
EP0693479A4 (de) Neue aconitin ähnliche verbindung und antipyretisches, analgetisches und entzündungshemmendes mittel
ATE386510T1 (de) Trägermatrix mit wirkstoffbeladenen partikeln zur anwendung auf der haut oder schleimhaut
SE9601527D0 (sv) Transdermally alministered acetylcysteine as mucolytic agent
PT1200071E (pt) Comprimidos fracamente doseados e processo de preparacao
EP1550667A4 (de) DIE TYROSINASEAKTIVITûT STEUERNDE MITTEL, VERFAHREN ZU DEREN HERSTELLUNG UND F R DIE ÜUSSERE ANWENDUNG BESTIMMTE ZUBEREITUNGEN, DIE DIESE ENTHALTEN
NO20013605L (no) Preparat for vorter
WO2004014943A3 (en) Biphalin derivates and their analgesic applications
CO5011042A1 (es) Uso de una oxazolidinona para la fabricacion de un medicamento para administracion topica
TR199700409T1 (xx) Harici kullan�ma mahsus enflamasyon �nleyici madde.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties